Amplifiers

Worldwide Polymerase Chain Reaction (PCR) for Point-of-Care Diagnostics Industry to 2025 - by Equipment, Kits and Region

Retrieved on: 
Friday, February 12, 2021

DUBLIN, Feb. 12, 2021 /PRNewswire/ -- The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 12, 2021 /PRNewswire/ -- The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics" report has been added to ResearchAndMarkets.com's offering.
  • The scope of this report is broad and covers the components available in the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market and potential end-users.
  • Revenue forecasts from 2020 to 2025 are given for types of kits and equipment, with estimated value derived from the revenues of manufacturers.
  • The report concludes with a look at the vendor landscape and includes detailed profiles of major vendors in the global PCR for POC diagnostics market.

Worldwide Molecular Point of Care Industry to 2025 - Featuring Abbott Laboratories, Aidian Oy and Akonni Biosystems Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, February 12, 2021

The "The Market and Future Potential for Molecular Point of Care" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Market and Future Potential for Molecular Point of Care" report has been added to ResearchAndMarkets.com's offering.
  • This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings.
  • Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting.
  • Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than an existing point of care systems.

Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas

Retrieved on: 
Thursday, February 11, 2021

Using the Assays Kit S-gene dropout in the presence of certain SARS-CoV-2 mutations, laboratories like Cytocheck can use Applied DNAs Assay Kit to identify virus-positive samples that may be a SARS-CoV-2 variant.

Key Points: 
  • Using the Assays Kit S-gene dropout in the presence of certain SARS-CoV-2 mutations, laboratories like Cytocheck can use Applied DNAs Assay Kit to identify virus-positive samples that may be a SARS-CoV-2 variant.
  • Applied DNA believes that the multi-S-gene-target design of its Assay Kit gives it a substantial advantage in the detection of certain variants.
  • Applied DNA is commercializing LinearDNA, its proprietary, large-scale polymerase chain reaction (PCR)-based manufacturing platform that allows for the large-scale production of specific DNA sequences.
  • Cytocheck Laboratory is an anatomic and clinical pathology laboratory located in Parsons, Kansas and is affiliated with MAWD Pathology of Kansas City.

Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market to 2025 - Featuring Abbott Laboratories, Atlas Genetics and Cepheid Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 11, 2021

The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics" report has been added to ResearchAndMarkets.com's offering.
  • The scope of this report is broad and covers the components available in the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market and potential end-users.
  • Revenue forecasts from 2020 to 2025 are given for types of kits and equipment, with estimated value derived from the revenues of manufacturers.
  • The report concludes with a look at the vendor landscape and includes detailed profiles of major vendors in the global PCR for POC diagnostics market.

GMED Global Now Offering Rapid COVID-19 PCR Testing in Houston

Retrieved on: 
Wednesday, February 10, 2021

In response to the CDC's travel guidelines and to help travelers meet the requirements for airline travel, GMED Global, LLC, an international health care institution specializing in medical education and health care workforce development and solutions for government and non-government organizations, today announced that it is offering next day PCR testing at both of its Houston Rapid COVID Clinics .

Key Points: 
  • In response to the CDC's travel guidelines and to help travelers meet the requirements for airline travel, GMED Global, LLC, an international health care institution specializing in medical education and health care workforce development and solutions for government and non-government organizations, today announced that it is offering next day PCR testing at both of its Houston Rapid COVID Clinics .
  • Widely regarded as the gold standard in viral testing, Rapid COVID Clinic's next day PCR testing offers travelers convenient, drive through access and highly accurate results with a quick turnaround.
  • PCR testing requirements vary by destination, and GMED recommends that travelers check with their airlines and travel destination to confirm which type of RT-PCR test is approved.
  • The address and operating hours for next-day PCR testing through GMED's Rapid COVID Clinic are as follows:

Syndromic Multiplex Diagnostic Markets, 2025 - COVID-19 Pandemic is Ushering in a New World of Infectious Disease Diagnostics

Retrieved on: 
Tuesday, February 9, 2021

Infectious Disease is Declining But..

Key Points: 

Infectious Disease is Declining But..
Syndrome Testing Moving to Big Instruments?
A Big Future for PCR?

Global Digital PCR Market (2020 to 2027) - by Treatment Type, Product Type, Application, and End-user

Retrieved on: 
Wednesday, February 3, 2021

The global digital polymerase chain reaction market is segmented into technology, type, application, end user, and region.

Key Points: 
  • The global digital polymerase chain reaction market is segmented into technology, type, application, end user, and region.
  • By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.
  • Product launch and acquisition was the most common strategies adopted among key players to expand their product offerings and strengthen their foothold in the global market.
  • This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.

Worldwide Nucleic Acid Amplification Detection and Diagnostics Industry to 2027 - Rising Prevalence of Chronic Conditions and Infectious Diseases Is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 3, 2021

According to this report the global nucleic acid amplification, detection, and diagnostics market is expected to reach US$ 38,162.68 million by 2027 from US$ 14,014.59 million in 2019.

Key Points: 
  • According to this report the global nucleic acid amplification, detection, and diagnostics market is expected to reach US$ 38,162.68 million by 2027 from US$ 14,014.59 million in 2019.
  • The report highlights trends prevailing in the global nucleic acid amplification, detection, and diagnostics market and the factors driving market along with those that act as hindrances.
  • Based on nucleic acid, the global nucleic acid amplification, detection, and diagnostics market is segmented into deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).
  • The growth of the nucleic acid amplification, detection, and diagnostics market is attributed to the factors such as increasing prevalence of chronic conditions and increasing demand for accurate and modern diagnostic measures.

Outlook on the Digital PCR Global Market to 2027 - Opportunity Analysis and Industry Forecast - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 3, 2021

The "Digital PCR Market by Treatment Type, Product Type, Application, and End User: Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digital PCR Market by Treatment Type, Product Type, Application, and End User: Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global digital polymerase chain reaction market generated $398 million in 2019, and is projected to reach $1,052 million by 2027, growing at a CAGR of 12.3% from 2020 to 2027.
  • By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.
  • This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.